Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $43.3 million.

  • Arcutis Biotherapeutics' Change in Acquisitions & Divestments fell 5221.82% to $43.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $229.7 million, marking a year-over-year decrease of 2010.84%. This contributed to the annual value of $288.8 million for FY2024, which is 2895.87% down from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Change in Acquisitions & Divestments of $43.3 million as of Q3 2025, which was down 5221.82% from $60.7 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Change in Acquisitions & Divestments ranged from a high of $147.5 million in Q1 2023 and a low of $36.0 million during Q3 2021
  • Over the past 5 years, Arcutis Biotherapeutics' median Change in Acquisitions & Divestments value was $68.0 million (recorded in 2023), while the average stood at $75.6 million.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Change in Acquisitions & Divestments skyrocketed by 31700.0% in 2021 and then tumbled by 5286.07% in 2024.
  • Arcutis Biotherapeutics' Change in Acquisitions & Divestments (Quarter) stood at $72.0 million in 2021, then rose by 11.68% to $80.4 million in 2022, then plummeted by 30.36% to $56.0 million in 2023, then rose by 2.28% to $57.3 million in 2024, then decreased by 24.41% to $43.3 million in 2025.
  • Its last three reported values are $43.3 million in Q3 2025, $60.7 million for Q2 2025, and $68.5 million during Q1 2025.